Delivery Order SPE2DB20D1100-SPE2DB25FC7E3

Award Date 6/5/25
Potential Completion Date 6/6/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of JARDIANCE 10 MG TABLET 90S, a medication used to treat diabetes. The contract has a ceiling value of $23,272.21 and a completion date of May 20, 2025. The contract is a firm-fixed-price type and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $23,839.81, is for the delivery of JARDIANCE 10 MG TABLET 90S, a medication used to treat diabetes. The contract is a firm fixed-price, delivery order type and has an ultimate completion date of February 20, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,793.85 firm fixed-price contract is for the supply of JARDIANCE 10 MG TABLET 90S, a medication used to treat type 2 diabetes. The contract has a performance period through June 4, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JARDIANCE 10 MG TABLET 90S, a medication used to treat diabetes. The contract has a ceiling value of $5,327.29 and is a firm fixed price contract. It has an ultimate completion date of June 4, 2025. Amerisourcebergen Drug Corp is also the prime contractor on a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JARDIANCE 25 MG TABLET 90S, a medication likely used to treat diabetes. The contract has a ceiling value of $34,871.22 and a completion date of May 23, 2025. It is a firm fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,000.73 firm fixed price contract is for the supply of JARDIANCE 10 MG TABLET 90S, a medication used to treat diabetes. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JARDIANCE 10 MG TABLET 90S, a diabetes medication, with a ceiling value of $24,860.73 and a performance period through June 5, 2025. The contract has a firm fixed price pricing type and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,927.48 firm fixed-price contract is for the supply of JARDIANCE 10 MG TABLET 90S, a medication used to treat diabetes. The contract has an ultimate completion date of January 16, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,531.15, is for the supply of JARDIANCE 10 MG TABLET 90S, a medication used to treat diabetes. The contract has an ultimate completion date of July 29, 2024. It is a Firm Fixed Price contract, and there is no set-aside designation mentioned. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JARDIANCE 10 MG TABLET 90S, a medication, with a ceiling value of $24,518.20 and a completion date of June 5, 2025. The contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FC7E3
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a pharmaceutical distribution and healthcare solutions provider. The contract is for the delivery of JARDIANCE 10 MG TABLET 90S, a medication used to treat diabetes. The contract has a ceiling value of $16,298.23 and is a firm fixed price delivery order. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 9/4/25, 9:55 AM